glp-1 news today recency 3 What's next for innovation: A primer on the race reshaping pharma and chronic disease care Fmr. FDA Commissioner weighs in

The platform, called LillyDirect, joins a growing field of websites offering telehealth prescriptions for weight loss drugs.

GLP-1s are among the most promising medical breakthroughs in decades, helping patients struggling with diabetes, obesity and other []

As part of this shift, Blue Cross Blue Shield of Michigan (Medicare) will now require members to start with Liraglutide, followed by step therapy before accessing other GLP-1s such as Ozempic or Wegovy

While GLP-1 medications have shown remarkable results for weight loss, they may also lead to some muscle loss

Your promise: Break through plateaus and accelerate your results

Novo Nordisk is buying three Catalent facilities for $11bn in a bid to resolve supply issues holding back growth of Ozempic for diabetes and obesity therapy Wegovy.